Navigation Links
Data on Xeomin® (incobotulinumtoxinA) in the Treatment of Blepharospasm to be Presented at the 115th Annual Meeting of the American Academy of Ophthalmology
Date:10/25/2011

between 18 and 80 years of age at 34 sites in the U.S. and Canada, from October 2006 to May 2008. Eligible patients (n=109) were randomized in a 2:1 ratio to receive XEOMIN or placebo and were followed up to 20 weeks. The selection of doses, dilution, volume and injection sites for treatment was based on the last two Botox® treatments (+/- 10%) prior to the start of the study. Up to 50 Units per eye was allowed.

At each visit, the severity and frequency of blepharospasm symptoms were assessed by the Jankovic Rating Scale (JRS), and the Blepharospasm Disability Index (BSDI) was used to evaluate the effect of XEOMIN on patients' functional impairment. The BSDI evaluates six specific activity items, including watching TV, shopping, walking, reading, driving a vehicle and doing everyday activities. In addition, JRS scores were determined by daily patient self-assessments.

A significant difference was observed in the primary efficacy variable (change in JRS severity subscore rated by an independent rater six weeks following treatment), favoring XEOMIN by 1.0 point (P<.001). No patients discontinued the study prematurely because of insufficient treatment efficacy or adverse events.

All patients who completed the placebo-controlled trial (n=102) were eligible to enter the OLEX, which involved repeat treatment with XEOMIN (up to five treatment sessions) over a period of up to 48 weeks. Investigators determined dosing (up to 50 Units per eye) and frequency of injections, with at least six weeks between sessions.

About XEOMINIn nature, Clostridium botulinum produces botulinum toxin in association with ancillary accessory proteins. Manufacturers utilize this naturally occurring protein complex to produce therapeutic botulinum toxin products. XEOMIN (incobotulinumtoxinA) is manufactured using a proprietary process that isolates the therapeutic component and removes accessory proteins.

More than 250,000 patients have be
'/>"/>

SOURCE Merz Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
2. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
3. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
4. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
5. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
6. New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinsons Disease And Movement Disorders (MDS)
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015  PinnacleHealth CardioVascular Institute enrolled the first patient ... the United States in a trial assessing ... for blockages in the main artery of the leg. The ... potentially less risk for stent fracture or re-narrowing after the ... multicenter clinical trial of the BioMimics 3D Stent System and ...
(Date:8/27/2015)... YORK , August 27, 2015 ... published by Persistence Market Research titled "Global Market ... Witness Highest Growth by 2021", the urinary catheters market is ... the end of 2015. It is anticipated to ... 2021, to reach US$1,755.0 Mn by 2021. ...
(Date:8/27/2015)... 2015  QB3@953—a San Francisco ... California (UC) research institute and biotech accelerator— today ... identify and facilitate collaborations to translate early drug ... The agreement formalizes a relationship between QB3@953 ... and creates a new channel for DPAc to ...
Breaking Medicine Technology:First Pennsylvania Patient Treated in Landmark Vascular Study 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4QB3@953 Signs Collaboration Agreement with GSK to Identify Early-Stage Drug Discovery Opportunities 2
... Berger Health System, recognized as one of the ... to AutoCarousel® HD by Talyst, a leader of pharmacy ... has a built-to-last 10 years guarantee. Berger ... is also implementing AutoPharm®, AutoPack™ and AutoLabel® to help ...
... Lineagen, Inc., an innovative molecular diagnostics company focused on ... nonprofit subsidiary of the National Multiple Sclerosis Society, today ... validation of a blood-based assay for multiple sclerosis (MS). ... test that can aid clinicians in diagnosing MS, distinguishing ...
Cached Medicine Technology:Berger Health System Partners With Pharmacy Automation Leader to Improve Patient Safety 2Lineagen and Fast Forward Collaborate to Develop Gene and Biomarker-Based Clinical Assays for Multiple Sclerosis 2Lineagen and Fast Forward Collaborate to Develop Gene and Biomarker-Based Clinical Assays for Multiple Sclerosis 3Lineagen and Fast Forward Collaborate to Develop Gene and Biomarker-Based Clinical Assays for Multiple Sclerosis 4
(Date:8/27/2015)... , ... August 27, 2015 , ... Sunbelt® Bakery, maker ... fructose corn syrup, is changing the expectation of how protein bars should taste with ... taste unlike any other protein bar on the market today. , The new ...
(Date:8/27/2015)... ... August 27, 2015 , ... Healthpointe clinics are now ... Bernardino, and Orange County. , Designed to accommodate the busy lifestyles and ... all of its locations. Executive Physicals are scheduled so that busy professionals ...
(Date:8/27/2015)... ... August 27, 2015 , ... Standifer Insurance ... Birmingham Alabama, is launching a joint charity drive with the Meadow View Elementary ... qualify for assistance programs, and many lack the simple supplies necessary for a ...
(Date:8/27/2015)... ... August 27, 2015 , ... A study conducted in Italy suggests that it ... to chemotherapy. Surviving Mesothelioma has just posted an article on the new research. ... Milan treated mesothelioma cells with different concentrations of the chemotherapy drug cisplatin. ...
(Date:8/27/2015)... ... , ... When hiking in hot, dry weather, the three things that must ... legs and the eyes. Of the three, the eyes are the most frequently neglected ... about accelerated evaporation, dehydration and dry eye. Hiking dry eye will be the topic ...
Breaking Medicine News(10 mins):Health News:Sunbelt® Bakery Changes the Expectations of How Protein Bars Should Taste with the Introduction of Its New Protein Delights 2Health News:Sunbelt® Bakery Changes the Expectations of How Protein Bars Should Taste with the Introduction of Its New Protein Delights 3Health News:Healthpointe Now Offering Executive Physicals 2Health News:Standifer Insurance Group Initiates Charity Drive to Provide School Supplies for Underprivileged Meadow View Elementary Students 2Health News:Standifer Insurance Group Initiates Charity Drive to Provide School Supplies for Underprivileged Meadow View Elementary Students 3Health News:Scientists Say Enzymes May Influence Chemotherapy Response in Mesothelioma, According to Surviving Mesothelioma 2Health News:Hiking Can Cause Dry Eye in Long, Hot, Dry Summer of 2015 but Is Preventable 2Health News:Hiking Can Cause Dry Eye in Long, Hot, Dry Summer of 2015 but Is Preventable 3
... Angiography plus anti-clotting drug keep tissue viable, researchers say ... treatment can help save severely frostbitten limbs that might ... severe frostbite, deep tissue freezing can damage muscles, tendons, ... limb amputation, according to background information in the study. ...
... Kim Watson to Expand Global Partnerships for Clean Pesticide and Animal ... ... March 17 TyraTech (AIM:,TYR), a pioneer of safer, effective and ... markets, announced today,the appointment of Kim Watson as Senior Director Business ...
... sets record date of March 24, 2008 ... Shareholders vote approves Hillenbrand Industries name change to Hill-Rom Holdings, Inc., at separation; ... Inc., at separation, -- "Ex-Distribution" and "When Issued" Trading expected to commence March ... ...
... Inc. (NYSE:,CNO) today announced that it is declining a ... its representatives to Conseco,s board of,directors. Conseco also announced ... the investment banking firm of Morgan Stanley,as its strategic ... with Steel Partners, as well as,our other shareholders, a ...
... Randy Jackson, music industry,veteran and TV personality, is ... local community about type 2 diabetes and its ... American Heart,Association to speak on behalf of a ... living with type 2 diabetes manage the disease,and ...
... Tropical Traditions,announced today that they added Organic Raw Coconut ... be the first product of its kind introduced,to the ... of coconuts is a,cottage industry in the Philippines, and ... is highly valued due to its high concentration of,nutrients. ...
Cached Medicine News:Health News:Therapy Could Save Limbs After Frostbite 2Health News:TyraTech Adds New Sr. Director Business Development 2Health News:TyraTech Adds New Sr. Director Business Development 3Health News:Hillenbrand Industries Announces Formal Board Approval of Separation by Means of Share Distribution and Details for Completion 2Health News:Hillenbrand Industries Announces Formal Board Approval of Separation by Means of Share Distribution and Details for Completion 3Health News:Hillenbrand Industries Announces Formal Board Approval of Separation by Means of Share Distribution and Details for Completion 4Health News:Randy Jackson and the American Heart Association Educate Raleigh Area Residents About the Connection Between Type 2 Diabetes and Cardiovascular Disease 2Health News:Randy Jackson and the American Heart Association Educate Raleigh Area Residents About the Connection Between Type 2 Diabetes and Cardiovascular Disease 3Health News:Tropical Traditions Announces New Organic Raw Coconut Water Vinegar 2
... Suction Catheters With Contro-Vac Valve and DeLee ... Respiratory Suctioning, ,Medline's 6 and 8Fr, ... Tips are the optimal tools for treating ... forward placed suction valve to minimize mucous ...
Sterile Straight Packed TOUCH-TROL Suction Catheters...
Sterile Single Loop Pediatric Suction Catheters with TOUCH-TROL Valve...
Suction catheter with thumb valve, two eyes, whistle tip...
Medicine Products: